| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | A-kinase anchor protein 14;AKAP-14;A-kinase anchor protein 28 kDa;AKAP 28;Protein kinase A-anchoring protein 14;PRKA14;AKAP14;AKAP28; |
| Cellular Localization | |
| Clonality | |
| Concentration | |
| Gene ID | |
| Host | |
| Immunogen | A synthesized peptide derived from human MAS1L |
| Isotype | |
| Molecular Weight | |
| Product Type | |
| Reactivity | |
| Reconstitution | |
| Target | |
| UniProt # |
Boster Bio Anti-MAS1L Rabbit Monoclonal Antibody catalog # M16029. Tested in WB, IP applications. This antibody reacts with Human.
Protein: T-cell surface glycoprotein CD3 zeta chain | Gene: A-kinase anchor protein 14 | Target: MAS1L | Function: Binds to type II regulatory subunits of protein kinase A and anchors/targets them. | Research areas: Protein Phosphorylation,Ser/Thr Kinases,Signal Transduction
Host: Rabbit | Clonality/Clone: Monoclonal / Clone: 29M28 | Isotype: IgG | Reactivity: Human | Immunogen: A synthesized peptide derived from human MAS1L | Concentration: 0.5mg/ml | Purification: Affinity-chromatography
Applications: WB, IP
Observed MW: 37 kDa | Calculated MW: 22815 MW
Cellular localization: Cytoplasm .
Tissue details: Widely expressed with highest levels in brain, kidney and muscle. .
Status: Active
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
